News & Updates
Filter by Specialty:
Glaucoma in patients with diabetes ups risk of diabetic retinopathy
Diabetic patients with primary open-angle glaucoma (POAG) are at greater risk of developing diabetic retinopathy (DR), reveals a study, noting the need for screening and comprehensive management in glaucomatous patients with diabetes to reduce the risk of DR.
Glaucoma in patients with diabetes ups risk of diabetic retinopathy
06 Jul 2024
Nadofaragene firadenovec promotes bladder preservation in BCG-unresponsive NMIBC
Nadofaragene firadenovec-vncg helps preserve the bladder in patients with bacillus Calmette-Guérin (BCG)-unresponsive nonmuscle-invasive bladder cancer (NMIBC) at 5 years, with an acceptable safety profile, as shown in a phase III trial.
Nadofaragene firadenovec promotes bladder preservation in BCG-unresponsive NMIBC
05 Jul 2024
SABR yields better survival, tumour control in oligometastatic HCC
Treatment with stereotactic ablative radiotherapy (SABR) results in excellent local tumour control and improves survival among patients with oligometastatic hepatocellular carcinoma (HCC), with no serious adverse effects, reports a study.
SABR yields better survival, tumour control in oligometastatic HCC
05 Jul 2024
9-month, oral modified treatment regimens make the grade in drug-resistant TB
Nine-month, fully oral modified short treatment regimens (mSTRs) consisting of bedaquiline, linezolid, levofloxacin, clofazimine, and cycloserine or delamanid appear to yield high treatment success and good safety results in the treatment of patients with rifampicin-resistant, fluoroquinolone-susceptible tuberculosis (TB), according to a study.